Literature DB >> 25223849

DMSO containing ruthenium(ii) hydrazone complexes: in vitro evaluation of biomolecular interaction and anticancer activity.

M Alagesan1, P Sathyadevi, P Krishnamoorthy, N S P Bhuvanesh, N Dharmaraj.   

Abstract

Synthesis, spectral, electrochemical and single crystal X-ray diffraction data of a new series of DMSO containing bivalent ruthenium hydrazone complexes are presented. XRD data of two of the new complexes revealed an octahedral coordination around the ruthenium ion satisfied by NOS2Cl2 atoms. Electrochemical studies showed the metal centred, quasi-reversible, one-electron redox behaviour of the new complexes. The binding of these complexes with biomolecules such as calf thymus DNA (CT-DNA) and bovine serum albumin (BSA) protein investigated by different spectrophotometric methods revealed an intercalative mode of interaction. The in vitro cytotoxicity of these complexes evaluated by the MTT assay on a panel of cancer and normal cell lines indicated that the above complexes are more toxic to cancer cells with a few micromolar concentrations as the IC50 value, but are significantly less toxic to normal cell lines. The observed variations in the binding interactions and cytotoxicity of the complexes were attributed to the nature of the hydrazide moiety of the hydrazones that influences their biological activities.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25223849     DOI: 10.1039/c4dt01032a

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  5 in total

1.  DNA Damage Response Checkpoint Activation Drives KP1019 Dependent Pre-Anaphase Cell Cycle Delay in S. cerevisiae.

Authors:  Lindsey A Bierle; Kira L Reich; Braden E Taylor; Eliot B Blatt; Sydney M Middleton; Shawnecca D Burke; Laura K Stultz; Pamela K Hanson; Janet F Partridge; Mary E Miller
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

2.  Half-Sandwich Arene Ruthenium(II) and Osmium(II) Thiosemicarbazone Complexes: Solution Behavior and Antiproliferative Activity.

Authors:  Anna Gatti; Abraha Habtemariam; Isolda Romero-Canelón; Ji-Inn Song; Bindy Heer; Guy J Clarkson; Dominga Rogolino; Peter J Sadler; Mauro Carcelli
Journal:  Organometallics       Date:  2018-02-20       Impact factor: 3.876

3.  Design, synthesis and characterization of novel chromone based-copper(ii) antitumor agents with N,N-donor ligands: comparative DNA/RNA binding profile and cytotoxicity.

Authors:  Farukh Arjmand; Zeenat Afsan; Thierry Roisnel
Journal:  RSC Adv       Date:  2018-11-06       Impact factor: 4.036

4.  Ruthenium Complexes Bearing α-Diimine Ligands and Their Catalytic Applications in N-Alkylation of Amines, α-Alkylation of Ketones, and β-Alkylation of Secondary Alcohols.

Authors:  Sekar Gayathri; Periasamy Viswanathamurthi; Roberta Bertani; Paolo Sgarbossa
Journal:  ACS Omega       Date:  2022-09-07

5.  Ruthenium(II)/(III) DMSO-Based Complexes of 2-Aminophenyl Benzimidazole with In Vitro and In Vivo Anticancer Activity.

Authors:  Shadia A Elsayed; Shane Harrypersad; Heba A Sahyon; Mohammed Abu El-Magd; Charles J Walsby
Journal:  Molecules       Date:  2020-09-18       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.